Ruiz-Garcia et al. performed ELISA measurement of anti-β2GPI IgA in 156 patients with clinical criteria of APS and they demonstrated isolated positivity of anti-β2GPI IgA in 22.4% [44]. Here, CD79A is linked to autoimmune polyendocrinopathy.